<SEC-DOCUMENT>0002072045-25-000009.txt : 20250710
<SEC-HEADER>0002072045-25-000009.hdr.sgml : 20250710
<ACCEPTANCE-DATETIME>20250710195002
ACCESSION NUMBER:		0002072045-25-000009
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250710
DATE AS OF CHANGE:		20250710

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Quantum Biopharma Ltd.
		CENTRAL INDEX KEY:			0001771885
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91661
		FILM NUMBER:		251117324

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		55 UNIVERSITY AVENUE, SUITE 1003
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2H7
		BUSINESS PHONE:		(416) 854-8884

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		55 UNIVERSITY AVENUE, SUITE 1003
		CITY:			TORONTO
		PROVINCE COUNTRY:   	A6
		ZIP:			M5J 2H7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FSD Pharma Inc.
		DATE OF NAME CHANGE:	20190327

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Malone Wealth Ventures LLC
		CENTRAL INDEX KEY:			0002072045
		ORGANIZATION NAME:           	
		EIN:				861544286
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		9201 W STATE ST. STE 126
		CITY:			BOISE
		STATE:			ID
		ZIP:			83714
		BUSINESS PHONE:		2089854526

	MAIL ADDRESS:	
		STREET 1:		9201 W STATE ST. STE 126
		CITY:			BOISE
		STATE:			ID
		ZIP:			83714
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0002072045-25-000001</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0002072045</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>5</amendmentNo>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>07/10/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001771885</issuerCik>
        <issuerName>Quantum Biopharma Ltd.</issuerName>
        <issuerCusip>74764Y205</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>55 UNIVERSITY AVENUE, SUITE 1003</com:street1>
          <com:street2>55 UNIVERSITY AVENUE, SUITE 1003</com:street2>
          <com:city>TORONTO</com:city>
          <com:stateOrCountry>A6</com:stateOrCountry>
          <com:zipCode>M5J 2H7</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Malone Wealth Ventures LLC</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>103601.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>735148.00</soleDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>735148.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>19.4</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <comments>Les Gro</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Quantum Biopharma Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>55 UNIVERSITY AVENUE, SUITE 1003, 55 UNIVERSITY AVENUE, SUITE 1003, TORONTO, ONTARIO, CANADA, M5J 2H7.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Malone Wealth Ventures LLC</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>9201 W State St. Ste 126
Boise, ID 83714</principalBusinessOfficeOrResidenceAddress>
        <citizenship>United States</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>735148</amountBeneficiallyOwned>
        <classPercent>19.4</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>103601</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>735148</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Clients of Malone Wealth Ventures LLC have the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of, the securities reported herein. No individual client is known to have such interest relating to more than five percent of the class.
</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Malone Wealth Ventures LLC</reportingPersonName>
      <signatureDetails>
        <signature>Kevin M Malone</signature>
        <title>President &amp; CEO</title>
        <date>07/10/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
